Nuvation Bio Inc. (NUVB) Cash Flow Statement
Nuvation Bio Inc. (NUVB) generated -$120.5M of operating cash flow over the twelve months to 2026-06-30, spent $8.4M on capital expenditure and had free cash flow of -$128.9M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NUVBNuvation Bio Inc.Follow NUVB — free
—
Price chart with a free account
- Market cap
- 1.6B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|
| Operating cash flow | -130.4 | -173.4 | -120.5 | |
| Capital expenditure | 0.2 | 8.4 | -8.4 | |
| Free cash flow | -130.6 | -181.8 | -128.9 | |
| Stock-based compensation | 32.3 | 35.9 | — |
USD millions · SEC XBRL
Nuvation Bio Inc. — questions
- What is Nuvation Bio Inc.'s operating cash flow?
- -$120.5M over the twelve months to 2026-06-30.
- How much does Nuvation Bio Inc. spend on capital expenditure?
- $8.4M over the twelve months to 2026-06-30.
- What is Nuvation Bio Inc.'s free cash flow?
- -$128.9M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Nuvation Bio Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.